Evidence map›Paper›PMID 40434677›Full record

ReviewCurrent oncology reports2025

Acute Management of Hypercalcemia of Malignancy - A Review of Pathophysiology, Diagnosis, and Treatment.

Ashley Crouch, Aysha Chaudhri, Sonya Khan, Maggie Ma, Ngoc Vu, William Towers

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ashley CrouchDepartment of Pharmacy, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.ORCID http://orcid.org/0000-0002-5803-5762
Aysha ChaudhriDepartment of Endocrine Neoplasia and Hormonal Disorders, MD Anderson Cancer Center, 5927 Almeda Rd, Unit 21414, Houston, TX, 77004, USA.
Sonya KhanDepartment of Endocrine Neoplasia and Hormonal Disorders, MD Anderson Cancer Center, 5927 Almeda Rd, Unit 21414, Houston, TX, 77004, USA.
Maggie MaDepartment of Pharmacy, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.ORCID http://orcid.org/0000-0002-4313-5744
Ngoc VuDepartment of Pharmacy, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.ORCID http://orcid.org/0000-0002-7779-3091
William TowersDepartment of Pharmacy, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. will_towers@hotmail.com.ORCID http://orcid.org/0000-0002-3965-8374

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewHypercalcemia of malignancy is one of the most common metabolic disorders in patients with cancer and is associated with significant morbidity and mortality. This narrative review summarizes pathophysiology, clinical presentation, diagnostic strategies, and therapies available for the management of hypercalcemia of malignancy in acutely ill adult patients. RECENT

findingsWe reviewed both classic and recent literature to provide practical recommendations for managing cancer-related hypercalcemia. Our findings are presented in the context of recently published societal guidelines. Timely identification and treatment of acute hypercalcemia of malignancy is vital. Understanding of the underlying disease processes and available therapies is needed to optimize patient care and healthcare resource utilization.

Indexed as

HypercalcemiaNeoplasmsParaneoplastic SyndromesHumansDiagnosisHypercalcemiaMalignancyTreatment

Identifiers

PMID40434677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.